Clinical Trials Browser

Phase 2 × Recurrence × Immunotherapy × Clear all

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Oropharyngeal Neoplasms, Recurrence

NCT04981665 2022-01-05

A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Phase 2 Unknown

50 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Clinical Trials

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection